136 related articles for article (PubMed ID: 19081507)
41. Prognostic and predictive factors for breast cancer: translating technology to oncology.
Hayes DF
J Clin Oncol; 2005 Mar; 23(8):1596-7. PubMed ID: 15755959
[No Abstract] [Full Text] [Related]
42. [What is happening within cancer drug therapy? The Danish Society of Medical Oncology].
Dansk Selskab for Medicinsk Onkologi's bestyrelse (DMO)
Ugeskr Laeger; 2001 Mar; 163(12):1708. PubMed ID: 11284408
[No Abstract] [Full Text] [Related]
43. [New therapeutic strategies in oncology].
Bohuon C
Ann Pharm Fr; 2010 Jul; 68(4):203-4. PubMed ID: 20637352
[No Abstract] [Full Text] [Related]
44. The chemoprevention of cancer: directions for the future.
Daly MB
Cancer Epidemiol Biomarkers Prev; 1993; 2(6):509-12. PubMed ID: 8268765
[No Abstract] [Full Text] [Related]
45. GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials.
Chang SM; Reynolds SL; Butowski N; Lamborn KR; Buckner JC; Kaplan RS; Bigner DD
Neuro Oncol; 2005 Oct; 7(4):425-34. PubMed ID: 16212807
[TBL] [Abstract][Full Text] [Related]
46. Personalized cancer therapy--the key to the future.
Sikora K
Pharmacogenomics; 2004 Apr; 5(3):225-8. PubMed ID: 15102537
[No Abstract] [Full Text] [Related]
47. What are the challenges in pediatric oncology?
Voûte PA
Med Pediatr Oncol; 2002 Oct; 39(4):469-71. PubMed ID: 12203666
[No Abstract] [Full Text] [Related]
48. Themed issue on Cancer Nanotechnology.
Grodzinski P
Integr Biol (Camb); 2013 Jan; 5(1):17-8. PubMed ID: 23179042
[No Abstract] [Full Text] [Related]
49. Clinical Trial Considerations in Neuro-oncology.
Lee EQ
Curr Treat Options Oncol; 2021 Jul; 22(9):78. PubMed ID: 34213625
[TBL] [Abstract][Full Text] [Related]
50. Conventional cancer therapy: promise broken or promise delayed?
Tannock IF
Lancet; 1998 May; 351 Suppl 2():SII9-16. PubMed ID: 9606361
[No Abstract] [Full Text] [Related]
51. Development trends for monoclonal antibody cancer therapeutics.
Reichert JM; Valge-Archer VE
Nat Rev Drug Discov; 2007 May; 6(5):349-56. PubMed ID: 17431406
[TBL] [Abstract][Full Text] [Related]
52. [Current trends in clinical chemotherapy of tumors].
Garan AM
Vopr Onkol; 1983; 29(1):93-8. PubMed ID: 6823764
[No Abstract] [Full Text] [Related]
53. [Oncological surgery -- surgical oncology].
Siewert JR
Dtsch Med Wochenschr; 2005 Jun; 130(25-26):1566-7. PubMed ID: 15965864
[No Abstract] [Full Text] [Related]
54. [Future cancer care challenges the health care].
Olofsson S
Lakartidningen; 2010 Apr 21-27; 107(16):1065. PubMed ID: 20476702
[No Abstract] [Full Text] [Related]
55. Brain and nervous system.
Curr Opin Oncol; 1997 Jul; 9(4):B65-70. PubMed ID: 9303643
[No Abstract] [Full Text] [Related]
56. Neurofibromatosis type 2: A challenge for the neurosurgical medical community.
Kalamarides M
Neurochirurgie; 2018 Nov; 64(5):333-334. PubMed ID: 30243463
[No Abstract] [Full Text] [Related]
57. [Current treatments of vulvar cancer].
Mathevet P
J Gynecol Obstet Biol Reprod (Paris); 2012 Oct; 41(6):519-25. PubMed ID: 22580162
[TBL] [Abstract][Full Text] [Related]
58. Molecular probes in neuro-oncology: the future.
Bigner SH
Cancer Invest; 1990; 8(3-4):445-6. PubMed ID: 2207771
[No Abstract] [Full Text] [Related]
59. Coding for neuro-oncology.
Cohen BH
Continuum (Minneap Minn); 2015 Apr; 21(2 Neuro-oncology):487-98. PubMed ID: 25837909
[No Abstract] [Full Text] [Related]
60. Proceedings of the 36th annual meeting of the Nordisk Neurokirurgisk Forening (Scandinavian Neurosurgical Society). September 12-15, 1984, Stockholm, Sweden.
Acta Neurochir (Wien); 1985; 78(3-4):164-76. PubMed ID: 4091057
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
